Sun A.Kaken Company,Limited

4234.T
Specialty Chemicals
2026/08/21 Updated
Market Cap: $59.4M (¥9.4B)
Stock Price: $6.16 (¥980)
Exchange Rate: 1 USD = ¥158.98

FY2026 (Year Ending March 2026) Fiscal Year 117 Results Briefing Materials

FY117 Term (Year ending March 2026) Consolidated results released. Net sales of 30,358 million yen (up 3.2% year over year), operating profit of 837 million yen, turning to profitability. Segment-wise, profitability contributed by Functional Materials. For FY118, net sales outlook around 30,600 million yen, pursuing earnings improvements and productivity enhancements across segments.

Importance:
Page Updated: July 12, 2026
IR Disclosure Date: June 9, 2026
Financial Results

Key Figures

  • Sales: 30,358 million yen (YoY +3.2%)
  • Operating profit: 837 million yen (significant positive swing to profitability year over year)
  • Net income attributable to owners of the parent: 957 million yen (YoY +299.4%)
  • FY118 forecasted net sales: 30,600 million yen (YoY +0.8%)

AI要約

Financial Highlights

The consolidated results for FY117 show net sales of 30,358 million yen (up 3.2% year over year) and an operating profit of 837 million yen, achieving profitability and substantial improvement. By segment, Functional Materials posted net sales of 7,345 million yen and a significant contribution to profitability, aiding overall earnings structure. Selling, general and administrative expenses were 3,351 million yen, down 1.0% year over year. Profit before tax was 1,040 million yen, and net income attributable to equity holders of the parent was 957 million yen, a substantial increase.

Outlook and Initiatives for Next Term

For FY118, the earnings forecast is net sales of 30,600 million yen (up 0.8% year over year) and operating profit of 940 million yen (up 12.3%), aiming for earnings stability and improvement in Lightweight Packaging Materials and Industrial Materials through segmental growth in Functional Materials. Key initiatives include strengthening the earnings base, productivity reforms such as labor-saving and automation, and achieving No.1 in quality, delivery timing, and responsiveness. Capital expenditure is planned at 1,100 million yen, and R&D expenditure is kept at 400 million yen.

売上高推移

営業利益推移

セグメント別売上高

営業利益率推移

来期予想と実績の比較

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Sun A. Kaken Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →